Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption

SUMMARY: Abaloparatide, a novel PTH1 receptor agonist, increased bone formation in osteopenic ovariectomized cynomolgus monkeys while increasing cortical and trabecular bone mass. Abaloparatide increased bone strength and maintained or enhanced bone mass-strength relationships, indicating preserved...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Osteoporos Int
Main Authors: Doyle, N., Varela, A., Haile, S., Guldberg, R., Kostenuik, P. J., Ominsky, M. S., Smith, S. Y., Hattersley, G.
Formato: Artigo
Idioma:Inglês
Publicado: Springer London 2017
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5834552/
https://ncbi.nlm.nih.gov/pubmed/29260289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-017-4323-6
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares